Laurus Labs Limited (NSE:LAURUSLABS)
India · Delayed Price · Currency is INR 1,787.30
-64.40 (-3.48%)
Aug 14, 2026, 3:15 PM IST
Laurus Labs Market Cap
Laurus Labs has a market cap or net worth of 964.89 billion as of August 14, 2026. Its market cap has increased by 107.08% in one year.
Market Cap
964.89B
Enterprise Value
990.25B
Revenue
72.70B
Ranking
n/a
PE Ratio
88.36
Stock Price
1,787.30
ChartMarket Cap Chart
Since December 19, 2016, Laurus Labs's market cap has increased from 47.44B to 964.89B, an increase of 1,933.99%. That is a compound annual growth rate of 36.61%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 14, 2026 | 964.89B | 61.31% |
| Dec 31, 2025 | 598.16B | 84.05% |
| Dec 31, 2024 | 325.01B | 40.17% |
| Dec 29, 2023 | 231.86B | 14.74% |
| Dec 30, 2022 | 202.07B | -30.12% |
| Dec 31, 2021 | 289.18B | 52.60% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 19, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Divi's Laboratories | 2.28T |
| Zydus Lifesciences | 1.20T |
| Cipla | 1.18T |
| Mankind Pharma | 1.00T |
| Aurobindo Pharma | 959.15B |
| Alkem Laboratories | 655.22B |
| Glenmark Pharmaceuticals | 646.24B |
| Gland Pharma | 476.93B |